From Idea to Market: Product Lifecycle Management in the Pharmaceutical Industry (Market Focus)

The pharmaceutical industry produces increasingly complex products, with reduced time-to-market windows, and stringent domestic and international regulatory and compliance requirements. Datamonitor views PLM technology as one of the most rapidly growing market due to its inherent focus on time to market and product development, key business priorities in the pharmaceutical industry.



Report Highlights
Product lifecycle management will transform the drug development lifecycle process PLM addresses key business challenges facing the pharmaceutical industry Successful PLM for the pharmaceutical industry prevails over several constraining factors


[Fade out the market survey infos]

DATAMONITOR VIEW 1
CATALYST 1
SUMMARY 1
ANALYSIS 2
Product lifecycle management will transform the drug development lifecycle process 2
The nature of a drug's lifecycle necessitates a PLM strategy 2
PLM addresses key business challenges facing the pharmaceutical industry 3
A greater focus on decreasing time to market is driving adoption of PLM 4
Harmonizing product portfolios from M&A activities sets the stage for PLM 4
Reducing the challenges and cost associated with regulatory compliance 5
The nature of the pharmaceutical drug pipeline is changing 6
Complexity of pharmaceutical products is increasing 6
The end of the Blockbuster era signifies more candidates in the pipeline 6
Successful PLM for the pharmaceutical industry prevails over several constraining factors 6
Repurposing software from other industries makes the pharmaceutical industry suspicious 6
The traditional autonomous-business-unit mentality inhibits adoption of PLM 8
PLM does not mean an antidote to new product development 8
ACTIONS 9
Articulate strategic business benefits of your PLM investment decisions 9
Take a holistic approach to PLM 9
Understand how PLM changes the lifecycle processes of a pharmaceutical product 9
APPENDIX 10
APPENDIX 10
Definitions 10
Abbreviations 10
References 10
Methodology 10
Further reading 10
Ask the analyst 11
Datamonitor consulting 11
Disclaimer 11

[Fade out table of contents]

Table 1: Global PLM spending in the pharmaceutical industry by sector 2006-2012 8


Figure 1: The pharmaceutical product lifecycle is highly regulated, more complex and longer than other industries 3
Figure 2: Drug discovery licensing dependence of the top 10 pharmaceutical companies 5
Figure 3: Drug discovery licensing dependence of the top 10 pharmaceutical companies 7

[Fade out list of tables / figures]